Dermatitis atopic
Not recruitingStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
- Disease:Dermatitis atopic
- Substances:Rocatinlimab
Poland- Participants:18–64 years · 65+ years
- Substances:Rocatinlimab
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Poland34 clinical trials in Malbork, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Studies focusing on various skin conditions including genital psoriasis, atopic dermatitis, and chronic hand eczema. Research evaluates new topical treatments and systemic therapies for improved patient outcomes.
Novel therapeutic approaches aim to address both symptoms and underlying causes of skin disorders.
Clinical investigations targeting conditions like Sjögren's Syndrome and lupus erythematosus. Research focuses on evaluating innovative treatments for managing systemic manifestations and improving quality of life.
Studies aim to develop targeted therapies for complex autoimmune conditions.
Research examining treatments for hypertriglyceridemia and gastroparesis. Studies evaluate medication efficacy for managing metabolic disorders and digestive system conditions.
Innovative approaches focus on improving patient outcomes in metabolic and digestive disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.